Compare ARDX & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | BLZE |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 996.8M | 945.8M |
| IPO Year | 2014 | 2021 |
| Metric | ARDX | BLZE |
|---|---|---|
| Price | $3.83 | $14.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $15.14 | $7.60 |
| AVG Volume (30 Days) | ★ 4.8M | 3.6M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.56 |
| EPS | N/A | ★ N/A |
| Revenue | $2,607,000.00 | ★ $145,835,000.00 |
| Revenue This Year | $37.75 | $10.16 |
| Revenue Next Year | $34.24 | $10.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.27 |
| 52 Week Low | $3.73 | $3.26 |
| 52 Week High | $8.40 | $23.99 |
| Indicator | ARDX | BLZE |
|---|---|---|
| Relative Strength Index (RSI) | 27.50 | 44.22 |
| Support Level | N/A | $3.93 |
| Resistance Level | $6.47 | $18.25 |
| Average True Range (ATR) | 0.14 | 1.12 |
| MACD | 0.01 | -0.57 |
| Stochastic Oscillator | 12.33 | 5.48 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.